Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Melinda Gooderham

Showing results (1-10 of 178) with videos related to

Pageof 18
Sort By:
Skin Therapy Letter|December 6, 2013
Small molecules: an overview of emerging therapeutic options in the treatment of psoriasisMelinda Gooderham
Psoriasis (Auckland, N.Z.)|February 2, 2018
Management of scalp psoriasis: current perspectivesKim Blakely, Melinda Gooderham
Pharmaceutics|February 25, 2023
Targeting Interleukin 13 for the Treatment of Atopic DermatitisYuliya Lytvyn, Melinda Gooderham
JAAD Case Reports|November 11, 2020
Asymptomatic SARS-CoV2 infection in a patient receiving risankizumab, an inhibitor of interleukin 23Madison Ward, Melinda Gooderham
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 21, 2015
Selective Phosphodiesterase Inhibitors for Psoriasis: Focus on ApremilastMelinda Gooderham, Kim Papp
Skin Therapy Letter|September 21, 2023
Topical Roflumilast for Plaque PsoriasisAshley O'Toole, Melinda Gooderham
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|February 22, 2005
Use of hyaluronic acid for soft tissue augmentation of HIV-associated facial lipodystrophyMelinda Gooderham, Nowell Solish
Journal of the American Academy of Dermatology|October 17, 2015
The psychosocial impact of hidradenitis suppurativaMelinda Gooderham, Kim Papp
Current Problems in Dermatology|November 14, 2017
Clinical Trial and Registry DataMelinda Gooderham, Kim Papp
Journal of Cutaneous Medicine and Surgery|March 24, 2019
The Use of Janus Kinase Inhibitors in Vitiligo: A Review of the LiteratureNicole Relke, Melinda Gooderham
Pageof 18

Showing results (1-10 of 178) with videos related to

Sort By:
Pageof 18
Skin Therapy Letter|December 6, 2013
Small molecules: an overview of emerging therapeutic options in the treatment of psoriasisMelinda Gooderham
Psoriasis (Auckland, N.Z.)|February 2, 2018
Management of scalp psoriasis: current perspectivesKim Blakely, Melinda Gooderham
Pharmaceutics|February 25, 2023
Targeting Interleukin 13 for the Treatment of Atopic DermatitisYuliya Lytvyn, Melinda Gooderham
JAAD Case Reports|November 11, 2020
Asymptomatic SARS-CoV2 infection in a patient receiving risankizumab, an inhibitor of interleukin 23Madison Ward, Melinda Gooderham
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|October 21, 2015
Selective Phosphodiesterase Inhibitors for Psoriasis: Focus on ApremilastMelinda Gooderham, Kim Papp
Skin Therapy Letter|September 21, 2023
Topical Roflumilast for Plaque PsoriasisAshley O'Toole, Melinda Gooderham
Dermatologic Surgery : Official Publication for American Society for Dermatologic Surgery [Et Al.]|February 22, 2005
Use of hyaluronic acid for soft tissue augmentation of HIV-associated facial lipodystrophyMelinda Gooderham, Nowell Solish
Journal of the American Academy of Dermatology|October 17, 2015
The psychosocial impact of hidradenitis suppurativaMelinda Gooderham, Kim Papp
Current Problems in Dermatology|November 14, 2017
Clinical Trial and Registry DataMelinda Gooderham, Kim Papp
Journal of Cutaneous Medicine and Surgery|March 24, 2019
The Use of Janus Kinase Inhibitors in Vitiligo: A Review of the LiteratureNicole Relke, Melinda Gooderham
Pageof 18